Jada system technological updates cleared


The FDA has given 510(k) clearance to Organon for technological updates for its Jada system, which is designed to treat and control postpartum uterine bleeding or hemorrhage when conservative management is required. "Postpartum hemorrhage continues to be one of the most common complications of childbirth and this recent FDA clearance supports our ability to continue providing healthcare providers this important option for treating women with abnormal postpartum bleeding," said Organon CEO Kevin Ali in a statement.

Full story:

AdvaMed SmartBrief

Medical devices, health care information systems and diagnostic products

Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart.